The future of SRT looks promising with advancements in biotechnology and precision medicine. Research is ongoing to develop more specific and effective SRT drugs with fewer side effects. The integration of genetic and metabolic profiling can help tailor SRT to individual patients, improving efficacy. Furthermore, the combination of SRT with other therapeutic approaches, such as gene editing and advanced drug delivery systems, holds great potential for treating a broader range of metabolic disorders.
